Castle Biosciences (CSTL) Revenue (2018 - 2026)
Castle Biosciences (CSTL) revenue from Jun 30, 2018 to Mar 31, 2026. The TTM Castle Biosciences (CSTL) revenue is $340M. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual Revenue
Quarterly Revenue
Castle Biosciences (CSTL) Revenue CAGR table
| Period | CAGR |
|---|---|
| 1 Year TTM | -2.06% |
| 3 Years TTM | +30.70% |
| 5 Years TTM | +37.95% |
| All Time TTM | +48.86% |
Annual Revenue change of Castle Biosciences (CSTL)
| Year | Revenue | Change |
|---|---|---|
| 2026 | $84M | -75.69% |
| 2025 | $344M | +3.66% |
| 2024 | $332M | +51.09% |
| 2023 | $220M | +60.38% |
| 2022 | $137M | +45.65% |
| 2021 | $94M | +50.18% |
| 2020 | $63M | +20.78% |
| 2019 | $52M | +127.60% |
| 2018 | $23M | N/A |
Comparison Castle Biosciences (CSTL) five years revenue CAGR with competitors
Castle Biosciences (CSTL) five years revenue CAGR is 37.95%.